For now, Coke says it's just watching the increased interest and has not made any official decisions yet.
"Doubting Thomases have never taken our medical cannabis policy seriously since we announced it five years ago".
Coca-Cola Co (KO.N) is closely watching the fast-growing marijuana drinks market for a possible entry that would expand the world's largest soft drink maker's ambitions further away from sugary sodas.
Amazon's Bezos Slams Trump over Attacks on Media
He wrote that he wanted to help "people in the here and now - short term - at the intersection of urgent need and lasting impact". Bezos said Trump and other public figures should expect public and media scrutiny, which he called "healthy".
Coke is looking at "health-focused beverages that will ease inflammation, pain and cramping." according to Bloomberg.
Coca-Cola's statement shows the company has learned from its past missteps picking up on new drink trends, said Ali Dibadj, a senior analyst at AllianceBernstein with an expertise in United States beverage and snack food companies.
Canada's Freeland to hold NAFTA talks on Tuesday as time runs short
Teamsters Canada represents the interests of 125, 000 workers in all sectors of activity, including 5000 in the dairy industry. US President Donald Trump also said the talks, which both countries intensified in recent weeks, were coming along well.
A source close to the negotiations between the companies said: 'They're pretty advanced down the path of doing a deal.
Canada is the first major economy to legalize recreational marijuana, and shares in cannabis producers have rallied in anticipation. Similarly unclear is whether Coca-Cola would make a public announcement should the deal come to fruition (or if it would quietly white label a product under the Aurora brand). "It's going to be more of the "recovery drink" category", they added of the beverage.
Have you ever had a cannabis-infused drink? The drug is still illegal under U.S. federal law, although some states have decriminalized it. The first-ever medical treatment derived from a marijuana plant will hit the USA market soon, after regulators in June gave an epilepsy treatment by GW Pharmaceuticals the green light.
Berbatov backs Liverpool to see of Spurs on Saturday
The former right-back suggested that if the German wants to win the league, he should forget all about the Champions League .